Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
13 January 2026The global Dx AMR collaborative: an approach to strengthen the role of diagnostics in combating antimicrobial resistance
Antimicrobial resistance (AMR) is an escalating global health threat, with deaths linked to AMR projected to rise sharply from nearly 5 million in 2019 to more than 8 million by 2050. Despite this growing risk, international funding for AMR is declining, exemplified by the UK government’s 2025 decision to end support for the Fleming Fund, […]
Read more... -
08 January 2026A systematic review of antimicrobial stewardship practices and challenges in sub-Sahara Africa (SSA) regulated retail medicine settings
This systematic review assessed antimicrobial stewardship (AMS) practices in regulated retail medicine settings across sub-Saharan Africa and found substantial gaps between awareness and implementation. Based on 26 studies published between 2010 and mid-2024, the review shows that community pharmacists, accredited drug dispensers, and patent medicine vendors are generally aware of antimicrobial resistance (AMR) and the […]
Read more... -
02 January 2026Next-generation mRNA vaccines eliciting robust protection against multidrug-resistant Enterobacteriaceae
This study reports the development of next-generation mRNA vaccines targeting multidrug-resistant Enterobacteriaceae by encoding a fusion of two novel antigens, PstS and YidR. The mRNA vaccines showed high in-vitro expression and secretion and provided strong protection in mouse models against Klebsiella pneumoniae and enterohemorrhagic Escherichia coli, with marked reductions in bacterial burden and organ damage. […]
Read more...
More news related to Healthy patients
